Cappucci Gabriel R. 4

4 · Teladoc Health, Inc. · Filed Apr 17, 2020

Form 4

Period: 2017-04-16

Senior VP, Controller and CAO

Transactions

Sale
Common Stock
2020-04-16$169.16/sh−19,939$3,372,881→ 3,343 total
Sale
Common Stock
2020-04-16$165.93/sh−2,355$390,765→ 988 total
Exercise/Conversion
Employee Stock Option (right to buy)
2020-04-16−14,850→ 4,950 total
Exercise: $22.30Exp: 2027-03-03→ Common Stock (14,850 underlying)
Exercise/Conversion
Common Stock
2020-04-16$9.60/sh+2,734$26,246→ 6,077 total
Exercise/Conversion
Common Stock
2020-04-16$12.21/sh+2,355$28,755→ 8,432 total
Exercise/Conversion
Common Stock
2020-04-16$22.30/sh+14,850$331,155→ 23,282 total
Exercise/Conversion
Employee Stock Option (right to buy)
2020-04-16−2,734→ 0 total
Exercise: $9.60Exp: 2025-04-22→ Common Stock (2,734 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2020-04-16−2,355→ 0 total
Exercise: $12.21Exp: 2026-03-07→ Common Stock (2,355 underlying)

Footnotes (5)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 2, 2020.
[F2]Represents the weighted average price of transactions ranging from $166.05 to $171.55. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
[F3]The option vested as to 25% of the shares on April 22, 2016. The remainder of the shares vested in 36 equal monthly installments thereafter.
[F4]The option vested as to 25% of the shares on March 7, 2017. The remainder of the shares vested in 36 equal monthly installments thereafter.
[F5]The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.

Documents

1 file